JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis

Nakatani, Satoshi; Ohara, Takahiro; Ashihara, Kaoru; Izumi, Chisato; Iwanaga, Shiro; Eishi, Kiyoyuki; Okita, Yutaka; Daimon, Masao; Kimura, Toshimi; Toyoda, Kazunori; Nakase, Hiroyuki; Nakano, Kazuhiko; Higashi, Masahiro; Mitsutake, Kotaro; Murakami, Tomoaki; Yasukochi, Satoshi; Okazaki, Shuhei; Sakamoto, Haruo; Tanaka, Hiroshi; Nakagawa, Ichiro; Nomura, Ryota; Fujiu, Katsuhito; Miura, Takashi; Morizane, Toshio

doi:10.1253/circj.cj-19-0549

Cited by 128 publications

(196 citation statements)

References 192 publications

(211 reference statements)

Supporting

Mentioning

185

Contrasting

Unclassified

Order By: Relevance

“…Thus, the JCS 2017 guideline strongly recommends that adult patients at high risk of IE receive prophylactic antibiotics prior to invasive dental procedures that involve bleeding, such as tooth extraction, periodontal surgery, implant surgery, scaling, and infected root canal procedures (Class I) 25 . These high‐risk patients include those with a prosthetic valve, history of IE, complex congenital heart disease, or history of systemic‐pulmonary shunt surgery.…”

Section: Treatment For Infective Endocarditismentioning

confidence: 99%

“…Although the European and American guidelines limit prophylactic antibiotics to only these high‐risk patients, 18 JCS guideline gives Class IIa recommendation even to moderate‐risk groups, including patients with congenital heart diseases, acquired valvular heart diseases, hypertrophic obstructive cardiomyopathy, and mitral valve prolapse with valve regurgitation. Prophylactic antibiotics are also recommended for patients with implanted medical devices such as a permanent pacemaker and defibrillator, or long‐term placement of a central venous line (Class IIb) 25 (Table 1). Table 2 shows the standard prophylactic administration of antibiotics for these dental procedures.…”

Section: Treatment For Infective Endocarditismentioning

confidence: 99%

“…A single‐oral dose of amoxicillin 2 g within 1 hour before the procedure is recommended. If the dose of amoxicillin is reduced for any reason, an additional dose of amoxicillin of 500 mg should be considered 5‐6 hours after the first dose 25 . During prophylactic administration, it is crucial that antimicrobial agents suppress the process by which bacteria in the blood adhere to the valve tissue and grow (6‐9 hours from the start of the procedure).…”

Section: Treatment For Infective Endocarditismentioning

confidence: 99%

“…In IE, the severity of valve damage and bacteremia, and the risk of embolism change every moment, depending on underlying cardiac disease, pathogens, complications, and patient background. Therefore, it is strongly recommended that the patient be treated by a heart team which consists of members with expertise in cardiology, cardiac surgery, infectious diseases, and neurology 18,25 …”

Section: Treatment For Infective Endocarditismentioning

confidence: 99%

See 3 more Smart Citations

Surgical treatment of heart valve disease: Considerations for the dental management

Sakaguchi

2020

Oral Science International

View full text Add to dashboard Cite

The number of valve surgeries is increasing with a change in the disease structure from rheumatic valvular heart disease (VHD) to arteriosclerotic or degenerative VHD. The treatment strategies for VHD have also been changing over the last two decades. Repair techniques for valve regurgitation have been established with excellent long‐term clinical results. As valve repair has advantages over prosthetic valve replacement in terms of avoidance of anticoagulation and reduced risk of valve infection, it has become the first choice for treatment of degenerative VHD even for infective endocarditis, which is closely related to dental procedures. With the development of technologies, minimally invasive cardiac surgery is evolving, including the introduction of video‐assisted or robotically assisted valve surgeries via minithoracotomy, or percutaneous transcatheter therapies. Notably, recently introduced transcatheter aortic valve replacement has shown excellent clinical results compared to surgical aortic valve replacement and has become a standard therapy for aortic stenosis in the elderly. Reoperative aortic valve replacement for degenerated bioprosthetic valve can also be performed using the transcatheter “Valve in Valve” technique. These minimally invasive approaches are likely to become more widely adopted and may determine the scope of therapeutic strategies for VHD into the future.

show abstract

Section: Treatment For Infective Endocarditismentioning

confidence: 99%

Section: Treatment For Infective Endocarditismentioning

confidence: 99%

Section: Treatment For Infective Endocarditismentioning

confidence: 99%

Section: Treatment For Infective Endocarditismentioning

confidence: 99%

See 2 more Smart Citations

Surgical treatment of heart valve disease: Considerations for the dental management

Sakaguchi

2020

Oral Science International

View full text Add to dashboard Cite

show abstract

“…При разработке положений по профилактике и лечению ИЭ Японского общества по кровообращению (Japanese Circulation Society, JCS), эксперты также основывались на опыте внедрения руководств других научных обществ [47], что отражено в обосновании, рекомендациях и списке использованной 3. Большое значение имеет соблюдение условий поддержания дентальной и кожной гигиены у больных промежуточного и высокого риска ИЭ, подробно изложенные в национальных и международных рекомендациях.…”

Section: рекомендации японского общества по кровообращению 2017 гunclassified

Antibiotic Prophylaxis of Infective Endocarditis: From the History of the Concept to Modern Recommendations (Review)

Тарадин

Ponomareva

Игнатенко

et al. 2020

Arhivʺ vnutrennej mediciny

View full text Add to dashboard Cite

The presented review highlights current understandings of prophylaxis for infective endocarditis (IE). The historic aspects of the concept development of antibacterial prophylaxis (ABP) for IE, the main approaches and the rationale for changing the principles of ABP in recent years are described. There are detailed clarifications of published international and national recommendations, in particular, of European Society of Cardiology, National Institute for Health and Clinical Excellence, American Heart Association/American College of Cardiology and Japanese Circulation Society. The critical estimation of earlier adopted international guidelines with analysis of influence of partial or absolute ABP restrictions on the incidence of IE and its complications including fatality rate are presented.

show abstract

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J‐SSCG 2020)

Egi

Ogura

Yatabe

et al. 2021

Acute Medicine & Surgery

Self Cite

View full text Add to dashboard Cite

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J‐SSCG 2020), a Japanese‐specific set of clinical practice guidelines for sepsis and septic shock created as revised from J‐SSCG 2016 jointly by the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine, was first released in September 2020 and published in February 2021. An English‐language version of these guidelines was created based on the contents of the original Japanese‐language version. The purpose of this guideline is to assist medical staff in making appropriate decisions to improve the prognosis of patients undergoing treatment for sepsis and septic shock. We aimed to provide high‐quality guidelines that are easy to use and understand for specialists, general clinicians, and multidisciplinary medical professionals. J‐SSCG 2016 took up new subjects that were not present in SSCG 2016 (e.g., ICU‐acquired weakness [ICU‐AW], post‐intensive care syndrome [PICS], and body temperature management). The J‐SSCG 2020 covered a total of 22 areas with four additional new areas (patient‐ and family‐centered care, sepsis treatment system, neuro‐intensive treatment, and stress ulcers). A total of 118 important clinical issues (clinical questions, CQs) were extracted regardless of the presence or absence of evidence. These CQs also include those that have been given particular focus within Japan. This is a large‐scale guideline covering multiple fields; thus, in addition to the 25 committee members, we had the participation and support of a total of 226 members who are professionals (physicians, nurses, physiotherapists, clinical engineers, and pharmacists) and medical workers with a history of sepsis or critical illness. The GRADE method was adopted for making recommendations, and the modified Delphi method was used to determine recommendations by voting from all committee members. As a result, 79 GRADE‐based recommendations, 5 Good Practice Statements (GPS), 18 expert consensuses, 27 answers to background questions (BQs), and summaries of definitions and diagnosis of sepsis were created as responses to 118 CQs. We also incorporated visual information for each CQ according to the time course of treatment, and we will also distribute this as an app. The J‐SSCG 2020 is expected to be widely used as a useful bedside guideline in the field of sepsis treatment both in Japan and overseas involving multiple disciplines.

show abstract

JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis

Cited by 128 publications

References 192 publications

Surgical treatment of heart valve disease: Considerations for the dental management

Surgical treatment of heart valve disease: Considerations for the dental management

Antibiotic Prophylaxis of Infective Endocarditis: From the History of the Concept to Modern Recommendations (Review)

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J‐SSCG 2020)

Contact Info

Product

Resources

About